Determination of Protein Requirement in Elderly Female Subjects 65-75 Yrs Old

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01578733

Recruitment Status : Completed

First Posted : April 17, 2012

Last Update Posted : August 19, 2013

Sponsor:

Collaborator:

Canadian Institutes of Health Research (CIHR)

Information provided by (Responsible Party):

Dr. Paul Pencharz, The Hospital for Sick Children

Study Description

Brief Summary:

Minimal data are available on protein requirements throughout the lifespan. Currently available recommendations are based on nitrogen balance data. The limitations of the nitrogen balance method have been well described. Importantly, nitrogen balanced underestimates requirements.

The current DRI requirement for healthy adult males is based on the reanalysis of the nitrogen balance date from Young and Scrimshaw. This data was reanalyzed statistically by Rand et al. and he concluded that the protein requirement of healthy adults was 0.65 and 0.83 (mean and RDA) g/kg/day of good quality protein. Using IAAO, the investigators group estimated the protein requirement of young men (mean age 27 years) to be 0.93 and 1.2 g/kg/day (mean and RDA).

Currently there are no studies on protein requirement in the elderly. In a recent nutrition survey conducted by NHANES, the authors concluded that adults between the ages of 51 - 70 years old consumed an average on 1.0 g/kg/day (ideal body weight) of protein which represents about 15 % of calories. Depending on the calculations used for ideal body weight some older adults could be getting higher or lower than requirement. There is no scientifically derived protein estimate for older adults. Therefore there is a need to measurer protein requirement in that population.

The goal of this study therefore is to measure the protein requirement of female elderly subjects between the ages of 65 - 70 years using the IAAO technique.

Condition or disease	Intervention/treatment	Phase
Healthy	Dietary Supplement: protein intake.	Not Applicable

Study Design


Study Type :	Interventional (Clinical Trial)
Actual Enrollment :	14 participants
Intervention Model:	Crossover Assignment
Masking:	None (Open Label)
Primary Purpose:	Health Services Research
Official Title:	Use of Indicator Amino Acid Oxidation Technique to Determine Protein Requirement of Elderly Female Subjects 65-75 Yrs Old
Study Start Date :	November 2011
Actual Primary Completion Date :	August 2012
Actual Study Completion Date :	August 2012

Arms and Interventions

Arm	Intervention/treatment
Experimental: protein intake different levels of protein intake	Dietary Supplement: protein intake. •Protein intakes will be varied at 0.2, 0.5, 0.7, 0.9,1.0, 1.2, 1.5, 1.8g, 2.0g/kg/day

Outcome Measures

Primary Outcome Measures :

13CO2 production [ Time Frame: Study Day 3 ]
Urine and breath samples will be collected on day 3 of the experiment in order to determine to rate of production of 13CO2, phenylalanine flux and oxidation.

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:	65 Years to 75 Years (Older Adult)
Sexes Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Healthy elderly females between the ages of 65 to 75 and >75 years
Willingness to participate in the study
Females without a chronic disease or acute illness that could affect protein and AA metabolism eg, diabetes, cancer, liver or kidney disease, HIV, acute cold or flu, hypo or hyperthyroidism, rheumatoid arthritis treated with anti-inflammatory medications.
Females with hypertension if well controlled by medications

Exclusion Criteria:

Presence of disease known to affect protein and AA requirement and synthesis like diabetes, cancer, liver o kidney disease, HIV, acute cold or flu, hypo or hyperthyroidism, rheumatoid arthritis treated with anti-inflammatory medications.
On medications known to affect protein and amino acid metabolism like e.g. steroids.
Significant weight loss during the past month.

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01578733

Locations


Canada, Ontario
The Hospital for Sick Children
Toronto, Ontario, Canada, M5G1X8

Sponsors and Collaborators

The Hospital for Sick Children

Canadian Institutes of Health Research (CIHR)

Investigators


Principal Investigator:	Paul Pencharz, MD	The Hospital for Sick Children

More Information


Responsible Party:	Dr. Paul Pencharz, Senior Sicentist, Research Institute, The Hospital for Sick Children, The Hospital for Sick Children
ClinicalTrials.gov Identifier:	NCT01578733 History of Changes
Other Study ID Numbers:	0019850580-A
First Posted:	April 17, 2012 Key Record Dates
Last Update Posted:	August 19, 2013
Last Verified:	August 2013

Keywords provided by Dr. Paul Pencharz, The Hospital for Sick Children:


protein requirement female elderly healthy female subject's protein requirements

To Top